Found: 1
Select item for more details and to access through your institution.
Anti–PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activation.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 751, p. 1, doi. 10.1126/scitranslmed.adj9672
- By:
- Publication type:
- Article